Golden State Warriors center Kevon Looney's season-best performance against the Oklahoma City Thunder cost him a broken nose injury. However, the injury does not appear likely to cost him any time.

B. Riley initiated coverage of Foghorn Therapeutics (FHTX) with a Buy rating and $10 price target. The firm says its investment thesis centers on the company’s strategy to inactivate or degrade ...

Foghorn Therapeutics (FHTX) has received a new Buy rating, initiated by B.Riley Financial analyst, Kalpit Patel. Kalpit Patel’s rating is based on Foghorn Therapeutics’ innovative approach to ...

Before proceeding with the final stretch of the show, Joe took a moment to highlight The Fearless Flyers’ fondness for L.A. and their feelings for all of their friends in the music industry who ...

BP will slash over 5% of its global workforce as part of CEO Murray Auchincloss’ efforts to reduce costs and rebuild investor confidence after the energy giant was rocked by scandal, the company ...